Background: Coronavirus disease 2019 (COVID-19) vaccines are highly effective for reducing severe disease and mortality. However, vaccine effectiveness data are limited from Sub-Saharan Africa. We report COVID-19 vaccine effectiveness against progression to in-hospital mortality in Zambia. Methods: We conducted a retrospective cohort study among admitted patients at 8 COVID-19 treatment centers across Zambia during April 2021 through March 2022, when the Delta and Omicron variants were circulating. Patient demographic and clinical information including vaccination status and hospitalization outcome (discharged or died) were collected. Multivariable logistic regression was used to assess the odds of in-hospital mortality by vaccination status, adjusted for age, sex, number of comorbid conditions, disease severity, hospitalization month, and COVID-19 treatment center. Vaccine effectiveness of ≥1 vaccine dose was calculated from the adjusted odds ratio. Results: Among 1653 patients with data on their vaccination status and hospitalization outcome, 365 (22.1%) died. Overall, 236 (14.3%) patients had received ≥1 vaccine dose before hospital admission. Of the patients who had received ≥1 vaccine dose, 22 (9.3%) died compared with 343 (24.2%) among unvaccinated patients (P < .01). The median time since receipt of a first vaccine dose (interquartile range) was 52.5 (28-107) days. Vaccine effectiveness for progression to in-hospital mortality among hospitalized patients was 64.8% (95% CI, 42.3%-79.4%). Conclusions: Among patients admitted to COVID-19 treatment centers in Zambia, COVID-19 vaccination was associated with lower progression to in-hospital mortality. These data are consistent with evidence from other countries demonstrating the benefit of COVID-19 vaccination against severe complications. Vaccination is a critical tool for reducing the consequences of COVID-19 in Zambia. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2022.
Background: Coronavirus disease 2019 (COVID-19) vaccines are highly effective for reducing severe disease and mortality. However, vaccine effectiveness data are limited from Sub-Saharan Africa. We report COVID-19 vaccine effectiveness against progression to in-hospital mortality in Zambia. Methods: We conducted a retrospective cohort study among admitted patients at 8 COVID-19 treatment centers across Zambia during April 2021 through March 2022, when the Delta and Omicron variants were circulating. Patient demographic and clinical information including vaccination status and hospitalization outcome (discharged or died) were collected. Multivariable logistic regression was used to assess the odds of in-hospital mortality by vaccination status, adjusted for age, sex, number of comorbid conditions, disease severity, hospitalization month, and COVID-19 treatment center. Vaccine effectiveness of ≥1 vaccine dose was calculated from the adjusted odds ratio. Results: Among 1653 patients with data on their vaccination status and hospitalization outcome, 365 (22.1%) died. Overall, 236 (14.3%) patients had received ≥1 vaccine dose before hospital admission. Of the patients who had received ≥1 vaccine dose, 22 (9.3%) died compared with 343 (24.2%) among unvaccinated patients (P < .01). The median time since receipt of a first vaccine dose (interquartile range) was 52.5 (28-107) days. Vaccine effectiveness for progression to in-hospital mortality among hospitalized patients was 64.8% (95% CI, 42.3%-79.4%). Conclusions: Among patients admitted to COVID-19 treatment centers in Zambia, COVID-19 vaccination was associated with lower progression to in-hospital mortality. These data are consistent with evidence from other countries demonstrating the benefit of COVID-19 vaccination against severe complications. Vaccination is a critical tool for reducing the consequences of COVID-19 in Zambia. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2022.
Authors: John Simwanza; Jonas Z Hines; Danny Sinyange; Nyambe Sinyange; Chilufya Mulenga; Sarah Hanyinza; Patrick Sakubita; Nelia Langa; Haggai Nowa; Priscilla Gardner; Ngonda Saasa; Graham Chitempa; James Simpungwe; Warren Malambo; Busiku Hamainza; Peter J Chipimo; Nathan Kapata; Muzala Kapina; Kunda Musonda; Mazyanga Liwewe; Consity Mwale; Sombo Fwoloshi; Lloyd B Mulenga; Simon Agolory; Victor Mukonka; Roma Chilengi Journal: Am J Trop Med Hyg Date: 2022-09-12 Impact factor: 3.707
Authors: Vladimir A Gushchin; Elena V Tsyganova; Darya A Ogarkova; Ruslan R Adgamov; Dmitry V Shcheblyakov; Nataliia V Glukhoedova; Aleksandra S Zhilenkova; Alexey G Kolotii; Roman D Zaitsev; Denis Y Logunov; Alexander L Gintsburg; Alexey I Mazus Journal: EClinicalMedicine Date: 2022-03-24
Authors: Nick Andrews; Julia Stowe; Freja Kirsebom; Samuel Toffa; Tim Rickeard; Eileen Gallagher; Charlotte Gower; Meaghan Kall; Natalie Groves; Anne-Marie O'Connell; David Simons; Paula B Blomquist; Asad Zaidi; Sophie Nash; Nurin Iwani Binti Abdul Aziz; Simon Thelwall; Gavin Dabrera; Richard Myers; Gayatri Amirthalingam; Saheer Gharbia; Jeffrey C Barrett; Richard Elson; Shamez N Ladhani; Neil Ferguson; Maria Zambon; Colin N J Campbell; Kevin Brown; Susan Hopkins; Meera Chand; Mary Ramsay; Jamie Lopez Bernal Journal: N Engl J Med Date: 2022-03-02 Impact factor: 91.245
Authors: Mark G Thompson; Karthik Natarajan; Stephanie A Irving; Elizabeth A Rowley; Eric P Griggs; Manjusha Gaglani; Nicola P Klein; Shaun J Grannis; Malini B DeSilva; Edward Stenehjem; Sarah E Reese; Monica Dickerson; Allison L Naleway; Jungmi Han; Deepika Konatham; Charlene McEvoy; Suchitra Rao; Brian E Dixon; Kristin Dascomb; Ned Lewis; Matthew E Levy; Palak Patel; I-Chia Liao; Anupam B Kharbanda; Michelle A Barron; William F Fadel; Nancy Grisel; Kristin Goddard; Duck-Hye Yang; Mehiret H Wondimu; Kempapura Murthy; Nimish R Valvi; Julie Arndorfer; Bruce Fireman; Margaret M Dunne; Peter Embi; Eduardo Azziz-Baumgartner; Ousseny Zerbo; Catherine H Bozio; Sue Reynolds; Jill Ferdinands; Jeremiah Williams; Ruth Link-Gelles; Stephanie J Schrag; Jennifer R Verani; Sarah Ball; Toan C Ong Journal: MMWR Morb Mortal Wkly Rep Date: 2022-01-21 Impact factor: 35.301
Authors: Mark W Tenforde; Wesley H Self; Manjusha Gaglani; Adit A Ginde; David J Douin; H Keipp Talbot; Jonathan D Casey; Nicholas M Mohr; Anne Zepeski; Tresa McNeal; Shekhar Ghamande; Kevin W Gibbs; D Clark Files; David N Hager; Arber Shehu; Matthew E Prekker; Anne E Frosch; Michelle N Gong; Amira Mohamed; Nicholas J Johnson; Vasisht Srinivasan; Jay S Steingrub; Ithan D Peltan; Samuel M Brown; Emily T Martin; Arnold S Monto; Akram Khan; Catherine L Hough; Laurence W Busse; Abhijit Duggal; Jennifer G Wilson; Nida Qadir; Steven Y Chang; Christopher Mallow; Carolina Rivas; Hilary M Babcock; Jennie H Kwon; Matthew C Exline; Mena Botros; Adam S Lauring; Nathan I Shapiro; Natasha Halasa; James D Chappell; Carlos G Grijalva; Todd W Rice; Ian D Jones; William B Stubblefield; Adrienne Baughman; Kelsey N Womack; Jillian P Rhoads; Christopher J Lindsell; Kimberly W Hart; Yuwei Zhu; Katherine Adams; Diya Surie; Meredith L McMorrow; Manish M Patel Journal: MMWR Morb Mortal Wkly Rep Date: 2022-03-25 Impact factor: 35.301